|
|
7,2''-dihydroxy-4''-methoxyisoflavan + NADPH + H+ + O2 <=> 10,2''-dihydroxy-4''-methoxy-isoflav-8-ene-7-one + NADP+ + H2O
|
1.14.13
|
–
|
|
MetaCyc:
RXN-16257
|
|
|
|
(-)-phaseollin + NADPH + H+ + O2 <=> 1alpha-hydroxyphaseollone + NADP+ + H2O
|
1.14.13
|
–
|
|
MetaCyc:
RXN-16218
|
|
|
|
(-)-maackiain + NADPH + H+ <=> 7,2''-dihydroxy-4,5''-methylenedioxyisoflavan + NADP+
|
1.1.1
|
–
|
|
MetaCyc:
RXN-16256
|
|
|
|
medicarpin + NADPH + H+ <=> 7,2''-dihydroxy-4''-methoxyisoflavan + NADP+
|
1.1.1
1.23.1
1.3.1
|
–
–
–
|
|
KEGG:
R07739
MetaCyc:
RXN-16255;
RXN-8936
|
|
|
|
(-)-maackiain + NADPH + H+ + O2 <=> 1alpha-hydroxy-maackiain + NADP+ + H2O
|
1.14.13
|
–
|
|
MetaCyc:
RXN-16215
|
|
|
|
medicarpin + NADPH + H+ + O2 <=> 1alpha-hydroxymedicarpin + NADP+ + H2O
|
1.14.13
|
–
|
|
MetaCyc:
RXN-16216
|
|
|
|
(+)-pisatin + reduced_[NADPH-hemoprotein_reductase] + O2 <=> (+)-6a-hydroxymaackiain + formaldehyde + oxidized_[NADPH-hemoprotein_reductase] + H2O
|
1.14.14
|
–
|
|
MetaCyc:
RXN-16217
|
|
|
|
7,2''-dihydroxy-4,5''-methylenedioxyisoflavan + NADPH + H+ + O2 <=> 10,2''-dihydroxy-4,5''-methylenedioxy-isoflav-8-ene-7-one + NADP+ + H2O
|
1.14.13
|
–
|
|
MetaCyc:
RXN-16258
|
|
|
|
Phaseollidin_hydrate <=> phaseollidin + H2O
|
4.2.1.97
phaseollidin hydratase
|
–
|
|
BRENDA:
BR469
KEGG:
R04728
MetaCyc:
4.2.1.97-RXN
|
|